| Drug Name | (Keytruda®(Pembrolizumab |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Patient Card
Healthcare provider guide
patient guide
Other
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
safety information about risk of Immune-Mediated Adverse Reactions and Infusion-Related Reactions |
| Patient card |
|
| patient guide |
|
| Health care provider guide |
|
| Dear Healthcare provider letter DHPC |
|